Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Students: IRS Tax Form 1098-T to be issued; return forms by Jan. 31
- Another session of discounted yoga offered at University Hospitals
- Three campus experts to discuss politics, possibilities of Hong Kong protests
- Anthropology’s Eileen Anderson-Fye examines changing gender roles
- New Michelson and Morley Bistro draws rave reviews